COVID and animal trials: A systematic review

Extensive work is being done to form targeted drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; however, it is imperative to have a safe and effective vaccine against the same to win the war against this pandemic. For creating an efficacious vaccine, a proper anim...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhamood Moothedath (Author), Muhaseena Muhamood (Author), Yadnit S Bhosale (Author), Aseem Bhatia (Author), Pranav Gupta (Author), Medapati Rama Haranadha Reddy (Author), Rahul V C Tiwari (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6563697ccbd74c70a3edc7a66a48c55f
042 |a dc 
100 1 0 |a Muhamood Moothedath  |e author 
700 1 0 |a Muhaseena Muhamood  |e author 
700 1 0 |a Yadnit S Bhosale  |e author 
700 1 0 |a Aseem Bhatia  |e author 
700 1 0 |a Pranav Gupta  |e author 
700 1 0 |a Medapati Rama Haranadha Reddy  |e author 
700 1 0 |a Rahul V C Tiwari  |e author 
245 0 0 |a COVID and animal trials: A systematic review 
260 |b Wolters Kluwer Medknow Publications,   |c 2021-01-01T00:00:00Z. 
500 |a 0975-7406 
500 |a 10.4103/jpbs.JPBS_749_20 
520 |a Extensive work is being done to form targeted drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; however, it is imperative to have a safe and effective vaccine against the same to win the war against this pandemic. For creating an efficacious vaccine, a proper animal model needs to be selected which can have an acceptable similarity of response as well as effects when administered to humans. For the present research, extensive search was conducted in MEDLINE and bioRxiv and medRxiv servers which were published in the English language from January 1, 2020, to August 20, 2020. Search terms included animal models, SARS-CoV-2, COVID-19, immune response against coronavirus, nonhuman primates, mice, ferrets, and macaques. In our study, creating an adequate immune response mimicking the response as in humans, as the endpoint, was considered as inclusion criterion while assessment of any additional therapies like safety as well as minimal tolerable dose using animal models as well as formation of adequate sample size of these models against COVID-19 was not considered. In our search, 163 articles were shortlisted, of them only 20 articles were finally included in our study which addressed to our inclusion and exclusion criterion. Our research articles focused on nonhuman primates, mice, hamsters, ferrets, cats, and dogs, with the main goal to investigate the role of animal models in the pathogenesis of COVID-19. It was evident in our research that animal models only mimic limited signs and symptoms experienced in COVID infection as compared to infections in humans. However, they are still essential to understand the pathogenesis, transmissibility of viral particles, and vaccine testing. 
546 |a EN 
690 |a animal models 
690 |a covid-19 
690 |a ferrets 
690 |a hamster 
690 |a nonhuman primate 
690 |a review 
690 |a rodent 
690 |a severe acute respiratory syndrome coronavirus 2 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
690 |a Analytical chemistry 
690 |a QD71-142 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacy and Bioallied Sciences, Vol 13, Iss 5, Pp 31-35 (2021) 
787 0 |n http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=5;spage=31;epage=35;aulast=Moothedath 
787 0 |n https://doaj.org/toc/0975-7406 
856 4 1 |u https://doaj.org/article/6563697ccbd74c70a3edc7a66a48c55f  |z Connect to this object online.